Author details

Full Name

Eric F Donaldson

Affiliation

ORCID

Career Start Year

2002

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37633256	Chronic Hepatitis B Finite Treatment: similar and different concerns with new drug classes.		2023
35077912	Communicating regulatory high-throughput sequencing data using BioCompute Objects.	Drug Discovery Today	2022
35259469	Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection.	Journal of Hepatology	2022
34980216	Assessing reproducibility of inherited variants detected with short-read whole genome sequencing.	Genome Biol	2022
34504347	Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.	Nat Biotechnol	2021
32473348	Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysis.	Clinical Gastroenterology and Hepatology	2021
32661400	Author Correction: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.	Nat Med	2020
31000465	2018 Ebola virus disease outbreak in Ã¿quateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation.	Lancet Infect Dis	2019
31783761	Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies.	Virology Journal	2019
30529300	Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus.	Gastroenterology	2019
31279814	In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products.	Antiviral Research	2019
29789360	Bat Caliciviruses and Human Noroviruses Are Antigenically Similar and Have Overlapping Histo-Blood Group Antigen Binding Profiles.	mBio	2018
30596645	Enabling precision medicine via standard communication of HTS provenance, analysis, and results.	PLoS Biol	2018
29435493	Conformational Occlusion of Blockade Antibody Epitopes, a Novel Mechanism of GII.4 Human Norovirus Immune Evasion.	mSphere	2018
29194682	Impact of hepatitis C virus polymorphisms on direct-acting antiviral treatment efficacy: Regulatory analyses and perspectives.	Hepatology	2018
28275452	Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation.	J Virus Erad	2017
28973354	Emergence of Novel Human Norovirus GII.17 Strains Correlates With Changes in Blockade Antibody Epitopes.	J Infect Dis	2017
28188908	HIVE-heptagon: A sensible variant-calling algorithm with post-alignment quality controls.	Genomics	2017
27050591	Corrigendum: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.	Nat Med	2016
25123381	Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir.	Hepatology	2015
25463617	A simian hemorrhagic fever virus isolate from persistently infected baboons efficiently induces hemorrhagic fever disease in Japanese macaques.	Virology	2015
26552008	A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.	Nat Med	2015
26508693	Regulatory evaluation of antiviral drug resistance in the era of next-generation sequencing.	Biomarkers in Medicine	2015
24872579	Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.	J Virol	2014
29054158	Corrigendum to "Each of the eight simian hemorrhagic fever virus minor structural proteins is functionally important" [Virology 462-463 (2014) 351-362].	Virology	2014
25449024	FDA perspective on sofosbuvir therapy for patients with chronic hepatitis C virus genotype 1 infection who did not respond to treatment with pegylated interferon and ribavirin.	Gastroenterology	2014
25275120	RNA populations in immunocompromised patients as reservoirs for novel norovirus variants.	J Virol	2014
24253287	Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses.	J Infect Dis	2014
24173225	Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.	J Virol	2014
25036340	Each of the eight simian hemorrhagic fever virus minor structural proteins is functionally important.	Virology	2014
24667706	A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.	mBio	2014
24939889	Standards for sequencing viral genomes in the era of high-throughput sequencing.	mBio	2014
24899184	Functional analyses of the three simian hemorrhagic fever virus nonstructural protein 1 papain-like proteases.	Journal of Virology	2014
24741081	Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.	J Virol	2014
23269783	Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.	J Virol	2013
24043791	Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.	Proc Natl Acad Sci U S A	2013
24217413	A decade after SARS: strategies for controlling emerging coronaviruses.	Nat Rev Microbiol	2013
23908476	Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.	J Infect Dis	2013
22090098	Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.	J Virol	2012
22696652	Increased antibody affinity confers broad in vitro protection against escape mutants of severe acute respiratory syndrome coronavirus.	J Virol	2012
22389731	Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.	PLoS Negl Trop Dis	2012
22615565	Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.	PLoS Pathog	2012
22993147	Evidence supporting a zoonotic origin of human coronavirus strain NL63.	J Virol	2012
23093932	Norovirus immunity and the great escape.	PLoS Pathog	2012
22072787	Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.	J Virol	2012
22090110	Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.	J Virol	2012
22180768	SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission.	Curr Opin Virol	2011
20980508	Norovirus GII.4 strain antigenic variation.	J Virol	2011
20980507	Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.	J Virol	2011
21593585	Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity.	RNA Biol	2011